11/25/2025
We can finally share that we're doing big things together with Clairity Inc. and Myriad Genetics to identify more women at risk for breast cancer!
For the first time ever, AI image-based risk, history-based risk models, and genetic risk insights are available in one integrated platform. This means clinicians can now see a more complete picture of a woman's risk and get her the follow-up and care she needs.
We're proud to be advancing breast cancer prevention and early detection alongside some of the best in business.
Come see us at RSNA booth #2507 to learn more!
Actionable offering helps enable earlier, more personalized breast cancer interventionsBOSTON and SALT LAKE CITY and FULTON, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Clairity, Myriad Genetics, Inc. (NASDAQ: MYGN), and MagView, today announced a joint collaboration in an effort to identify more women a...